3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Allodynia in 4 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "Agmatine, an endogenous cationic amine resulting from the decarboxylation of L-arginine, produces antihyperalgesic and antiallodynic effects in animal models of chronic neuropathic and inflammatory pain." | 3.74 | Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist. ( Courteix, C; Eschalier, A; Fialip, J; Hernandez, A; Pélissier, T; Privat, AM, 2007) |
| "Pretreatment with naloxone, an opioid receptor antagonist (1." | 1.31 | Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors. ( Moriyama, T; Okuda, K; Sakurada, C; Sakurada, S; Sakurada, T; Sugiyama, A; Tan-No, K; Watanabe, C, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courteix, C | 1 |
| Privat, AM | 1 |
| Pélissier, T | 1 |
| Hernandez, A | 1 |
| Eschalier, A | 1 |
| Fialip, J | 1 |
| Giovengo, SL | 1 |
| Kitto, KF | 1 |
| Kurtz, HJ | 1 |
| Velázquez, RA | 1 |
| Larson, AA | 1 |
| Sakurada, T | 1 |
| Watanabe, C | 1 |
| Okuda, K | 1 |
| Sugiyama, A | 1 |
| Moriyama, T | 1 |
| Sakurada, C | 1 |
| Tan-No, K | 1 |
| Sakurada, S | 1 |
| Ren, K | 1 |
| Williams, GM | 1 |
| Hylden, JL | 1 |
| Ruda, MA | 1 |
| Dubner, R | 1 |
4 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Allodynia
| Article | Year |
|---|---|
Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist.
Topics: Agmatine; Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Drug Interactions; Excitatory A | 2007 |
Parenterally administered kainic acid induces a persistent hyperalgesia in the mouse and rat.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Excitatory Amino Acid Agonists; Excitatory Amino Acid | 1999 |
Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Binding, Competitive; Di | 2002 |
The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics; Analysis of Variance; Animals; Behavior, Animal; C | 1992 |